Autism spectrum disorder in under 19s: recognition, referral and diagnosis

Clinical guideline
Reference number: CG128
Published: 28 September 2011
Last updated: 20 December 2017

Evidence

Evidence updates

Evidence update
Evidence update (PDF 608 KB)

Published:

18 November 2014

Supporting evidence

Surveillance report
2021 surveillance of autism (NICE guidelines CG128, CG142 and CG170)
Appendix A: Summary of evidence from surveillance (all 3 guidelines) (PDF 1.15 MB)

Published:

14 June 2021
Appendix B: Stakeholder consultation comments table (CG128) (PDF 1.02 MB)

Published:

14 June 2021
Appendix B: Stakeholder consultation comments table (CG142) (PDF 1.29 MB)

Published:

14 June 2021
Appendix B: Stakeholder consultation comments table (CG170) (PDF 1.53 MB)

Published:

14 June 2021
Surveillance report 2016 – Autism spectrum disorder in under 19s: recognition, referral and diagnosis (2011) NICE guideline CG128 and Autism spectrum disorder in under 19s: support and management (2013) NICE guideline CG170
Appendix A1: Summary of new evidence (PDF 478 KB)

Published:

22 September 2016
Evidence review
Evidence review A: Factors and neurodevelopmental disorders that increase the likelihood of a diagnosis of autism spectrum disorder (PDF 1.03 MB)

Published:

20 December 2017
Full guidance
Appendices (PDF 3.93 MB)

Published:

20 December 2017
Full guideline (PDF 7.8 MB)

Published:

20 December 2017